Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention

Table 1

MACCEs during 2-year follow-up.

Events		% of patients with MACCEs	% of all patients
All-cause death	7	6.09	0.71
Readmission for ACS	41	35.65	4.17
Unplanned repeat revascularization	53	46.09	5.39
Definite stent thrombosis	1	0.87	0.10
Ischemic stroke	13	11.30	1.32
In total	115	100	11.69

MACCE = major adverse cardiovascular and cerebrovascular event, ACS = acute coronary syndrome.